Skip to main content
. 2022 May 20;9:880014. doi: 10.3389/fnut.2022.880014

FIGURE 5.

FIGURE 5

Rank-bar chart with surface under the cumulative ranking (SUCRA) values for outcomes associated with synbiotics, probiotics, and prebiotics use in patients with non-alcoholic fatty liver disease (NAFLD).